Omega Healthcare Investors(OHI)
Search documents
Omega Healthcare Investors(OHI) - 2022 Q4 - Earnings Call Transcript
2023-02-03 18:55
Financial Data and Key Metrics Changes - The company reported its Q4 2022 earnings, with specific financial metrics to be discussed during the call [1] - Forward-looking statements regarding financial projections and conditions were highlighted, indicating potential risks and uncertainties [6] Business Line Data and Key Metrics Changes - Specific details regarding the performance of various business lines were not provided in the available content [1] Market Data and Key Metrics Changes - No specific market data or key metrics changes were mentioned in the provided content [1] Company Strategy and Development Direction - The company is focused on its financial projections, dividend policy, and portfolio restructuring as part of its strategic direction [6] Management Comments on Operating Environment and Future Outlook - Management acknowledged the risks and uncertainties that could affect actual results compared to forward-looking statements [6] Other Important Information - The call included a reminder that it was being recorded and that participants were in listen-only mode [1][8] Q&A Session Summary - No specific questions or answers from the Q&A session were included in the provided content [1]
Omega Healthcare Investors(OHI) - 2022 Q3 - Earnings Call Transcript
2022-11-03 18:29
Omega Healthcare Investors, Inc. (NYSE:OHI) Q3 2022 Earnings Conference Call November 3, 2022 10:00 AM ET Company Participants Michele Reber - Senior Director of Asset Management Taylor Pickett - Chief Executive Officer Robert Stephenson - Chief Financial Officer Daniel Booth - Chief Operating Officer Megan Krull - Senior Vice President of Operations Conference Call Participants Jonathan Hughes - Raymond James John Pawlowski - Green Street Advisors, LLC Michael Griffin - Citigroup Inc. David Rodgers - Rober ...
Omega Healthcare Investors(OHI) - 2022 Q3 - Quarterly Report
2022-11-03 15:34
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...
Omega Healthcare Investors(OHI) - 2022 Q2 - Earnings Call Transcript
2022-08-02 16:54
Omega Healthcare Investors, Inc. (NYSE:OHI) Q2 2022 Results Conference Call August 2, 2022 10:00 AM ET Company Participants Michele Reber - Senior Director, Asset Management Taylor Pickett - Chief Executive Officer Dan Booth - Chief Operating Officer Bob Stephenson - Chief Financial Officer Megan Krull - Senior Vice President, Operations Conference Call Participants Connor Siversky - Berenberg Jonathan Hughes - Raymond James Dave Rodgers - Baird Michael Griffin - Citi Daniel Bernstein - Capital One Nick Yul ...
Omega Healthcare Investors(OHI) - 2022 Q2 - Quarterly Report
2022-08-02 15:27
Financial Performance - Revenues for the three months ended June 30, 2022, totaled $244.6 million, a decrease of approximately $12.8 million compared to the same period in 2021[202]. - Expenses for the three months ended June 30, 2022, totaled $174.2 million, a decrease of approximately $0.9 million compared to the same period in 2021[202]. - Rental income for the six months ended June 30, 2022, was $428.3 million, a decrease of $30.4 million compared to the same period in 2021, primarily due to the impact of cash basis operators[206]. - Mortgage interest income for the six months ended June 30, 2022, was $40.1 million, a decrease of $7.5 million compared to the same period in 2021[206]. - Total other income for the six months ended June 30, 2022, was $133.9 million, an increase of approximately $58.8 million compared to the same period in 2021, mainly due to gains on asset sales[208]. - Nareit FFO for the three months ended June 30, 2022, was $160.6 million, compared to $180.8 million for the same period in 2021[212]. - General and administrative expenses for the six months ended June 30, 2022, were $35.2 million, an increase of $3.8 million compared to the same period in 2021[209]. - Acquisition, merger, and transition-related costs for the six months ended June 30, 2022, were $5.5 million, an increase of $3.7 million compared to the same period in 2021[209]. COVID-19 Impact - Omega Healthcare Investors, Inc. has reported that many operators have failed to make contractual payments under lease and loan agreements due to reduced revenue and increased expenses from the COVID-19 pandemic[158]. - Average occupancy levels in facilities have improved since early 2021 but have not returned to pre-pandemic levels, with ongoing staffing shortages impacting admissions[163]. - Federal relief efforts for healthcare providers were limited in 2021, and further government support is needed to offset the impacts of COVID-19 on operators[164]. - The company remains cautious about the long-term impact of COVID-19 on operators, particularly regarding staffing and occupancy recovery[167]. - The ongoing uncertainties related to COVID-19, including the impact of vaccination programs and potential new variants, continue to pose risks to the business[166]. - The ongoing impacts of COVID-19 have restricted operators from pursuing certain therapy efficiencies under PDPM, potentially affecting their financial performance[186]. Government Support and Regulations - The CARES Act authorized approximately $178 billion to be distributed through the Provider Relief Fund, with $9.5 billion specifically allocated for skilled nursing facilities (SNFs) and $2.5 billion tied to performance-based incentive payments[178]. - The American Rescue Plan Act increased the Federal Medical Assistance Percentage (FMAP) by 10 percentage points for state home and community-based services expenditures from April 1, 2021, to March 30, 2022[183]. - The Medicare sequester percentage is scheduled to return to 2% as of July 1, 2022, and will be extended through fiscal year 2031, impacting reimbursement rates for healthcare providers[180]. - Approximately $100 million in additional FMAP funds for nursing homes was approved by the State of Florida in November 2021, with a 7.8% increase in Medicaid reimbursement rates effective March 2022[183]. - The Centers for Medicare and Medicaid Services (CMS) has implemented quality of care initiatives, including staff vaccination requirements for over 15,000 Medicare and Medicaid-participating nursing homes[181]. - Regulatory changes in the healthcare industry could materially impact operators' financial conditions, affecting their ability to meet obligations to Omega[169]. - The healthcare industry is heavily regulated, and changes in laws and regulations can significantly affect the operations and financial conditions of operators[171]. Company Operations and Strategy - The company anticipates that the operating results of additional operators may be materially affected if government relief is insufficient, potentially leading to defaults on contractual obligations[164]. - Increased labor costs and shortages are expected to continue affecting operators, alongside heightened competition for facility acquisitions in the U.S.[168]. - The company is continuously evaluating its portfolio and may opportunistically sell assets or portfolios of assets as part of operator restructuring transactions[168]. - The company recorded impairments on six facilities totaling approximately $11.2 million during the same period, with $3.5 million related to facilities classified as held for sale[192]. - The company repurchased 5.2 million shares at an average price of $27.32 per share during the six months ended June 30, 2022, as part of a $500 million stock repurchase program[193]. - The company anticipates that its primary sources of cash will be adequate to fund cash flow needs through the next twelve months[213]. Cash Flow and Assets - Cash, cash equivalents, and restricted cash totaled $168.5 million as of June 30, 2022, an increase of $144.1 million compared to December 31, 2021[226]. - Operating activities generated $305.2 million of net cash flow for the six months ended June 30, 2022, a decrease of $73.1 million compared to the same period in 2021[227]. - Net cash flow from investing activities was an inflow of $277.2 million for the six months ended June 30, 2022, compared to an outflow of $387.1 million for the same period in 2021[228]. - Net cash flow from financing activities was an outflow of $436.8 million for the six months ended June 30, 2022, compared to an outflow of $54.3 million for the same period in 2021[229]. - As of June 30, 2022, total assets were $9.5 billion, total equity was $3.9 billion, and total debt was $5.4 billion, with debt representing approximately 57.7% of total capitalization[214]. - The weighted-average annual interest rate of the company's debt was 4.1%, with 98% of the debt having fixed interest payments as of June 30, 2022[215]. - As of June 30, 2022, the company had $214.5 million of commitments to fund construction and capital improvements[224].
Omega Healthcare Investors(OHI) - 2022 Q1 - Earnings Call Transcript
2022-05-03 18:56
Omega Healthcare Investors, Inc. (NYSE:OHI) Q1 2022 Earnings Conference Call May 3, 2022 10:00 AM ET Company Participants Michele Reber - Senior Director, Asset Management Taylor Pickett - Chief Executive Officer Dan Booth - Chief Operating Officer Bob Stephenson - Chief Financial Officer Megan Krull - Senior Vice President, Operations Conference Call Participants Jonathan Hughes - Raymond James Sam Choe - Credit Suisse Nick Joseph - Citi Connor Siversky - Berenberg Rich Anderson - SMBC John Pawlowski - Gre ...
Omega Healthcare Investors(OHI) - 2022 Q1 - Quarterly Report
2022-05-03 18:13
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...
Omega Healthcare Investors (OHI) Investor Presentation - Slideshow
2022-04-09 14:10
OMEGA HEALTHCARE INVESTORS INVESTOR PRESENTATION April 2022 Disclaimers; Forward-looking Statements and Non-GAAP Information • This presentation may include projections and other "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to future events and expectations and involve unknown risks and uncertainties. Omega's actual results or actions may differ materially from those projected in the forward-looking statements. For a summary ...
Omega Healthcare Investors(OHI) - 2021 Q4 - Annual Report
2022-02-17 16:30
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OMEGA HEALTHCARE INVESTORS, INC. (Exact Name of Registrant as Specified in its Charter) (Omega Healthcare Investors, Inc.) (Omega Healthcare Investors, Inc. ...
Omega Healthcare Investors(OHI) - 2021 Q4 - Earnings Call Transcript
2022-02-03 18:43
Omega Healthcare Investors, Inc. (NYSE:OHI) Q4 2021 Earnings Conference Call February 3, 2022 10:00 AM ET Company Participants Michele Reber - Director of Asset Management Taylor Pickett - CEO Robert Stephenson - CFO Daniel Booth - COO Megan Krull - Senior Vice President of Operations Conference Call Participants Jonathan Hughes - Raymond James Connor Siversky - Berenberg Nicholas Joseph - Citigroup Daniel Bernstein - Capital One Omotayo Okusanya - Credit Suisse Vikram Malhotra - Mizuho Andrew Rosivach ...